Stephen Neidle, D.Sc., Ph.D., Chairperson
Professor
University of London School of Pharmacy, London, England
stephen.neidle@pharmacy.ac.uk
Bill W. Day, Ph.D., Chairperson-elect
Professor, Dept. of Pharm. Sciences
Univ. of Pittsburgh School of Pharmacy, Pittsburgh, PA
bday@pitt.edu
Peter C. Dedon, M.D., Ph.D., Past Chairperson
Professor, Division of Bioengineering
Massachusetts Institute of Technology, Cambridge, MA
pcdedon@mit.edu
Kent S. Gates, Ph.D. (2009-2012)
Professor, Department of Chemistry
University of Missouri, Columbia, MO
gatesk@missouri.edu
Susan Nowell Kadlubar, Ph.D. (2010-2012)
Associate Professor, Division of Medical Genetics
University of Arkansas for Medical Sciences, Little Rock, AR
sakadlubar@uams.edu
Stephen A. Munk, Ph.D. (2011-2013)
Chief Executive Officer & President
Ash Stevens, Inc., Detroit, MI
samunk@ashstevens.com
|
Kevin G. Pinney, Ph.D. (2010-2012)
Professor, Department of Chemistry & Biochemistry
Baylor University, Waco, TX
kevin_pinney@baylor.edu
Thomas E. Smithgall, Ph.D. (2011-2013)
Professor & Chair, Microbiology & Molecular Genetics
University of Pittsburgh School of Medicine
tsmithga@pitt.edu
Melissa M. Vasbinder, Ph.D. (2010-2012)
Principal Scientist
AstraZeneca Pharmaceuticals, Waltham, MA
melissa.vasbinder@astrazeneca.com
Gregory D. Vite, Ph.D. (2011-2013)
Director, Discovery Chemistry
Bristol-Myers Squibb Co., Princeton, NJ
gregory.vite@bms.com
Matthew A. Marx, Ph.D. (2011-2013)
Director, Oncology Chemistry
Takeda Pharmaceutical Company Ltd., San Diego, CA
Matthew.marx@takedasd.com
|